Aroclor 1254 and Aroclor 1248, at doses of 11.7 and 4.7 mg/kg body weight (equivalent to 5 and 2 mg/kg/day), were given 3 days per week to groups of cynomolgus monkeys, and caused weight loss, fingernail loss, facial edema, epiphora, and death. Blood and adipose tissue PCB concentrations rose with the length of treatment. Tissue concentrations i n blood, adipose tissue, liver and kidneys were highest in monkeys treated with Aroclor 1254, 'reflecting dose differences. There was considerable variation, both within and between groups, in hematologic responses to PCB treatment. Aroclor 1254-treated monkeys had depressed and weakly responsive erythropoiesis. Aroclor 1248-treated monkeys had active but ineffective or depressed erythropoiesis with severe macrocytic or moderate normocytic anemia. Biochemical determination of blood serum constituents revealed treatment and time-related trends towards hypoalbuminemia and increased alkaline phosphatase, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transarninase, lactic dehydrogenase, cholesterol, triglycerides, total bilirubin and direct bilirubin values. Pathologic lesions common in both Aroclor groups were dilatation of meibomian glands duct; mucinous hyperplasia of the gastric mucosa; atrophy and loss of germinal centers in the splenic and other lymphoid follicles; enlargement, fatty degeneration, and necrosis of hepatocytes; bile duct and gall bladder epithelial cell hypertrophy and hyperplasia; and thyroid aberrations in follicular cell size and number of intracytoplasmic lysosomes. Lesions seen exclusively in an Aroclor 1254treated monkey were widespread mucinous metaplasia and hyperplasia of the fundic mucosa. The results suggest that in general, cynomolgus monkeys may be more refractory or less susceptible to PCB toxicity than rhesus monkeys and, that Aroclor 1248 may be more toxic than Aroclor 1254.
INTRODUCTION
Commercial polychlorinated biphenJls (PCB) are toxic mixtures containing many of the 209 possible congeners (15) . The presence of a large number of congeners in the various commercial mixtures makes analysis of individual congeners in these mixtures diffi-+a cult. For these reasons, analytical results are often reported in terms of total PCB concentration despite the well known fact that marked differences exist in the toxicity of individual chlorobiphenyls (22) .
PCB have been widely used in industry for approximately 50 years as adhesives, dielectric fluids in capacitors and transformers, heat transfer agents, plasticizers, and sealants (17) . Up until the occurrence of large-scale PCB contamination of cooking oil and the loss of 400,000 chickens because of PCB con-taminated chicken feed in Japan, as well as the destruction of 75,000 eggs in North Carolina in 1968, PCB were not regarded as chemicals of high toxicity (27) . Soon after, however, it was established that PCB contamination of the environment and the biota was worldwide. Later, a biologic magnification of PCB was demonstrated in the food chain (27) .
The adverse biologic effects of PCB vary, depending on the percentage composition of specific isomers, the presence of impurities and the animal species involved (11, 27) . The most commonly reported effects on humans are acneiform skin eruptions, pigmentation of nails and skin, eye discharge, generalized swelling, vomiting, diarrhea, decreased lung vital capacity, and fetal toxicity (9, 21) and a number of subjective symptoms including depression, dizziness, fatigue, headache, nervousness, sleeplessness and somnolence (4) . Additional effects observed in experimental animals fed the compounds are hepatic porphyria in chicken and rabbits (25, 26) , hepatic SER proliferation in rats (19) , mice and monkeys (18) , increase in certain hepatic enzyme activities in rats (19) , peripheral neuropathy in rats (20) , lymphopenia arid immunosuppression in rabbits (13, 24, 26), and increased incidence of abortions and stillbirths in monkeys (2, 11) .
Although an increasing amount of research is now being carried out with PCB, important questions on' the pathogenesis of PCB-induced tissue damage, the relative significance of target organ damage, as well as the dose-response relationship and no-effect level of maternal exposure to PCB, with observed toxicity to infants exposed in utero and via breast milk, remain largely unanswered.
Studies with non-human primates suggest that the rhesus monkey is a potentially useful model of human PCB toxicosis (1, 2, 7) . However, restrictions imposed by the unavailability and the high cost of these primates make these studies difficult. As reported in q previous communication (23), adult cynom6lgus (Macaca fascicularis) monkeys failed to develop overt clinical signs of PCB toxicity at doses (0.1 -0.4 mg Aroclor 1254/kg b.w./day) which produced severe toxicity in rhesus monkeys (1, 2) . Also, it could not be determined from that experiment whether the lack of toxicity in the cynomolgus monkey was due to species differences between rhesus and cynomolgus monkeys or whether it was due to differences in toxicity between Aroclor 1254 and Aroclor 1248 (1. 2). To determine if characterisiic signs of PCB toxicity could be induced in the cynomolgus by these PCB higher doses of Aroclor 1254 (5 mg/kg/ day) and Aroclor 1248 (2 mg/kg/day) were used in ihe present pilot study. The objectives of the pilot study described in this report were: 1) to determine the spectrum of clihical signs and lesions; 2) to define the relationship of PCB concentrations in organs and blood to extent of tissue damage; 3) (Table I) . Aroclor 1254 at a dose level of 11.7 mg/kg body weight and Aroclor 1248 at a dose level of 4.7 mg/kg b.w. were given three days/week (equivalent to 5 mg and 2 mg/kg b.w./day) in an apple juice-corn oil emulsion (23). Housing and feeding procedures were similar to those previously described (23).
PCB Analysis: Tissue PCB concentrations were determined at 14 day intervals in blood, at 28 day intervals in nuchal skin and fat, and terminally in liver and kidneys. Skin and fat biopsies, up to 100 mg each, were obtained under ketamine hydrochloride (Ketaset, Rogar/STB) anesthesia. The analytical methodology used was described previously (16) .
Clinical Pathology: Hematologic parameters measured were red blood cell counts (RBC), mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), hematocrit (Hct), hemoglobin (Hb), leukocyte counts-total (WBC) and differential, platelet counts, reticulocyte counts, and smears were evaluated for cell morphology. Re ticulocy tes were stained with me th ylene blue and blood smears with Leishman's stain. Femoral bone marrow was sampled terminally for differential counts and morphologic assessment, using a modified Leishman's staining method.
Serum biochemistry parameters, with the exception of triglycerides, were analyzed in a SMAC system (Technicon Corp. Terrytown, N.Y., U.S.A.), and included glucose, blood PCB TOXICITY IN CYNOMOL ;JS  TOXICOLOGIC PATHOLOGY   urea nitrogen, creatinine, uric acid, albumin,  total protein, cholesterol, total bilirubin, direct bilirubin, lactic dehydrogenase (LDH) , alkaline phosphatase (AP), serum glutamic oxaloacetic transaminase (SGOT), serum glutam.ic pyruvic transaminase (SGPT) and creat i n i n e p h 0s p h o k i n a s e (C P) . T r i gl y c e r i d e analysis, was accomplished with a test kit (BMC Diagnostics/Biochemicals Ltd). Cl in ical Exam in at ion: Clinical observations were recorded daily and complete clinical examinations were done at weekly intervals.
Necropsy: Monkeys were killed by exsanguination under ketamine hydrochloride anesthesia (Table I) . Two unexpected deaths were necropsied shortly thereafter. Tissues for histopathology were fixed in 10% neutral buffered formalin, ombedded in paraffin, cut and stained with hematoxylin and eosin (HE). Selected tissues were stained with periodic acid-Schiff (PAS), Avalone's periodic acid methena'mine silver, Alcian blue for mucopolysaccharides, and Gram stains.
RESULTS
Clinical Observations: During the first 25 days of dosing, monkeys in the Aroclor 1254 4 and No. 7) lost an averge 17.6% of body weight (range 14-22.9%) and those in the 1248 dose group lost a n average 13% (range 2.4-28.9%), whereas monkeys in the control group gained 3.3% in weight. Pretreated monkeys Nos. 4 and 7 lost 17. 5 and 23.1% of their body weight, respectively, during the same period. After approximately 50 days of dosing, surviving monkeys from both treatment groups reached relatively stable body weights ( Fig. 1) .
A list of the ty e and incidence of common were first observed is shown in Table 11 . Control monkeys remained clinically normal throughouf the experiment.
Chemical Analysis Findings: Blood PCB concentrations rose with the length of treatment but the rate of accumulation varied among animals in a given group as well as between groups (Table HI) . Although there was a large variation in blood PCB concentrations at necropsy, the blood of monkeys in the Aroclor 1254 group had higher PCB concentrations than that of monkeys in the Aroclor 1248 group. Mean blood PCB concentration was 40. 5 monkeys (#4, 7), and 6.4 -C 1.62 (S.E.) ppm for the 1248 group. Blood PCB concentrations continued to rise until the monkeys became moribund. The blood PCB concentration of monkeys $15 and #7 increased markedly on day 74 and 11 6, respectively ( Table 111 ). Blood PCB levels in control monkeys did not change during the course of the experiment (Mean = 0.002 ppm, range 0.001 to 0.005 pprn). The gas chromatographic pattern of the PCB residues in the blood of treated monkeys revealed an increase in the concentration of higher chlorinated biphenyls, known to accumulate in the body fat.
Adipose tissue PCB concentrations were determined on the basis of oil content as well as on the basis of whole sample weight (Table  IV) . The oil content of adipose tissue samples obtained from treated monkeys became markedly reduced as treatment progressed. The oil content of control adipose tissue samples remained constant during the course of the experiment (59.8 -C 4.0%). Based on oil content, PCB levels in adipose tissue samples increased until the monkeys were moribund. At necropsy, the PCB levels in adipose tissue oil was higher in the Aroclor 1254 group than in the Aroclor 1248 group. The mean values for each dose group, exluding the 2 pretreated monkeys, No. 4 corresponding control values were 0.163 -+ 0.063 ppm for liver and 0.093 2 0.033 ppm for kidney.
Clinical Pathologic Findings: The hematologic response to PCB treatment varied considerably among the monkeys (Tables VI and  VII) .
Of the three Aroclor 1254 monkeys, two (#6, 15) had depressed erythropoiesis with normal or slightly hypocellular marrow and no obvious blood manifestations of hematopoietic impairment (Table VI) . The third monkey (No. 17) had markedly hypocellular (Table VI) had bone marrow cellularity from normal to moderately hypocellular. There was moderately elevated to depressed erythropoietic activity, reduced myelopoiesis, variable lymphocytes, mild to severe predominantly normocytic anemia, low reticulocyte counts in two monkeys, and practically absent reticulocytes in one. Thrombocytopenia was observed in one monkey. Leukocyte counts were normal, moderately reduced, or severely reduced with degenerative shift to the left.
Of the five Aroclor 1248 treated monkeys, only 3 were examined terminally (Table VI) . Animals No. 9 and 13 had cellular bone marrow and normal marrow differential, moderate to severe macrocytic anemia ( Fig. 2 ), increased reticulocyte response, normal or increased leukocyte count with neutrophilia, and shift to the left. The third monkey (No. 12), had hypocellular marrow, depressed erythropoiesis, absence of megakaryocytes, absent granulocytic series and slightly Ole.vated lymphocytes, moderate normocytic anemia, normal reticulocyte count, severe leukopenia (neutropenia) and thrombocytopenia. Normal peripheral blood values were found in three control animals. A trend towards hypoalbuminemia and increased SGOT, SGPT and LDH was observed in treated monkeys as treatment progressed.
Gross Pathology: There was large variation in lesions among animals of the same group as well as between the two groups (Table  VIII) . The most common treatment related gross lesion was slight to moderate hepatic enlargement, present in 4 monkeys given Aroclor 1254 and 1 treated with Aroclor 1248. Histopathology: In order to facilitate a comparison between the effects of Aroclor 1254 and Aroclor 1248, histopathologic findings are described separately for each treatment level and the incidence of treatment-induced lesions is shown in Table IX. Aroclor 2 254 (5 mg/kg/day) Group. Eyelids. Dilatation of the tarsal meibomian gland duct and acini by retained material and, occasionally, by a few macrophages were seen in 5 monkeys ( Fig. 3 ). Lymphocytic infiltration of the lamina propria was present in two and increased goblet cells in the palpebral conjunctiva was seen in all monkeys from this group.
Lymphoreticular System. Splenic lesions were found in 5 monkeys. The germinal centers of Malpighian follicles from affected monkeys were either normal, small, indistinct, or absent ( Fig. 4 ). Small and indistinct germinal centers had a low mitotic index. Various degrees of focal to massive follicular proteinosis were present. The marginal zone contained either a normal number or a few lymphocytes, which were either palisading or loosely arranged. Lymphonodal lesions were qualitatively similar to those described for spleen and limited to germinal centers, which were present, but less prominent. Lymphocytes surrounding germinal centers were reduced, particularly in the monkey treated for the longest period. Similar lesions were seen in other tissues with lymphoretic- (+++I severe. 
Exagg. Hair follicles
Obesitv Table I. ular aggregates, such as Peyer's patches in the intestine. Thymic atrophy was advanced.
Thymic changes included absence of cocticomedullary differentiation and develo6k. ment of medullary cysts. Another lymphonodal lesion was the presence of numerous, pigment laden macrophages in the marginal and medullary sinuses of hilar lymph nodes. Digestive System. Diffuse hypertrophy and hyperplasia of the mucinous gastric epithelium was present in .all monkeys in this group, focal cystic dilatation of gastric glands in five, and early invasion of the submucosa by hyperplastic glands and near total loss of parietal (oxyntic) cells in one (Fig. 5 ). In sections stained with PAS or Alcian Blue hypertrophic and hyperplastic mucinous cells stained positively but typical goblet cells and a brush border were absent. The small and large intestines were unremarkable.
Hepatic lesions varied in severity and frequency and included uniform enlargement of centrolobular hepatocytes or clusters of hepatocytes with fraying or loss of hepatocellular margins; architectural distortion of hepatic plates, often with collapse of sinusoids, and vacuolation, presumably fatty degeneration, of centrilobular and midzonal hkpatocytes, occcasionally affecting clusters ofkepatocytes ( Fig. 6a ). Hepatocytic changes included ground glass appearance of the cytoplasm and pyknosis of the nuclei with or without neutrophil infiltration (Fig. 6b) ; eosinophilic necrosis of single or clusters of hepatocytes often with neutrophilic infiltration or collapse of the connective tissue framework; accumulation of intracytoplasmic eosinophilic inclusions; hypertrophy and hyperplasia of biliary duct epi thelium and biliary ducts (Fig. 6c) ; and moderate, diffuse sinusoidal fibrosis and hypercellularity, presumably secondary to hepatocytic necrosis. Gall bladder lesions ( Fig. 7) consisted of hypertrophy and hyperplasia, in some with cystic dilatation, of thc epithelium and intracytoplasmic eosinophilic inclusion bodies and autolysis. The lamina propria was unremarkable except for a small number of lymphocytessand plasma cells seen occasionally. Thyroid gland. Lesions of the thyroid were seen in all treated monkeys examined. The severity and spread of lesions, varied widely among animals. Most commonly encountered lesions included alterations in staining characteristics of the colloid; thickening of follicular epithelial cells and enlargement of nuclei; increased intracytoplasmic pigment granules, presumably lysosomes (Fig. 8 ); increase in the number of large follicles; alteration of follicular architecture as evidenced by intrafollicular septa lined by epithelial cells and ragged luminal follicular outline; and a variable number of desquamated fo)l,icular cells lying free in the colloid.
Other Systems. Lesions in other systems, were deemed to be unrelated to treatment and included mild focal chronic interstitial nephritis in one monkey, pleural thickening in three, terminal alveolar emphysema in four, focal non-resolving pneumonia and atelectasis in one, and sarcosporidiosis in one.
Aroclor 1248 (2 mg/kg/day) Group. Eyelids-Ta rsal, mei bomian , gland duct dilatation was present in 3 animals, chronic conjuncti-vitis in 2, increased goblet cells of the palpe-bra1 conjunctiva in 2, and varying degrees of lymphocytic infiltration in most monkeys (Fig. 3) .
Lymphoreticular System. Lesions in the splenic white pulp included absence, atrophy, and hyalinosis of germinal centers (Fig.  4 ). Lymphocytes of the marginal zone of atrophic follicies were seen palisading in 2 monkeys. The germinal centers of lymphoid follicles in lymph nodes were either small and hypoactive or absent. In some lymph nodes, all that was discerned was aggregated small lymphocytes. Also, the number of germinal centers in the lymphoreticular tissue of other organs, such as the stomach, intestine and lungs, was abnormally low. Thymic lesions consisted of reduced cortical cells and loss of cortico-medullary differentiation.
Digestive System. A slight to moderate degree of hypertrophic gastropathy was seen in all monkeys, cystic dilatation of gastric glands in three. Hepatic lesions (Fig. 6 Gall bladder lesions were difficult to assess because of advanced autolysis in two and severe chronic cholecystitis in one mdnkey. Epithelial hypertrophy and hyperplasia"was, however, seen in one monkey.
Thyroid gland. Thyroid changes were of a low grade, and included epithelial cell hypertrophy, accumulation of pigment granules in the cytoplasm, and focal neutrophilic infiltration. Autolysis was severe in one monkey.
Urinary System. Bacterial embolization of glomerular tufts and focal tubular necrosis were seen in one of the two monkeys dying on day 58 of txeatment.
Other Systems. Lesions found in other systems were interpreted to be spontaneous, and these lesions were pleural adhesions, alveolar emphysema, and focal granulomatous pneumonia due to acari infestation.
Control Group. Lesions seen in control monkeys were similar to those described as spontaneous in the Aroclor 1254 and Aroclor 1248 groups. Thus, pleural thickening, alveolar emphysema, focal interstitial nephri tis and occasional endometrial adenomyosis were deemed to be not uncommon alterations in these monkeys.
In general, the induced clinical signs were similar with both Aroclor compounds, irrespective of dose level, and resembled to a degree those previously reported for rhesus and cynomolgus monkeys (I, 2, 7 , 21) . The variation between groups in regards to time of onset of such signs as emaciation, facial edema, fingernail loss and moribund state was attributed to differences in dose level.
Correlation between PCB concentrations in organs and blood and severity of tissue damage was not achieved. Mean tissue and blood PCB concentrations in Aroclor 1254 treated monkeys were 3.2 to 6.3 times greater than in monkeys treated with Aroclor 1248. Such concentrations are deemed greater than whh! can be accounted for by the difference i ndose levels (2.5 times) alone, suggesting a) that Aroclor 1248 may be more potent in regard to hematopoietic and immune system damage, and b) 2 mg of Aroclor 1248/kg/day may provide as many biologically active congeners as 5 rng of Aroclor 1254/kg/day. Assuming the latter were true, the greater tissue PCB concentrations seen with Aroclor 1254 could in part be attributed to accumulation .-~ of biphenyls with the greater number of chlorine atoms.
The contribution of diffuse gastric mucinous hyperplasia, if any, in the establishment of progressive weight loss remains to be determined for at least two reasons. First, non specific oxyntic cell loss in man is capable of leading to hypoor even achlorhydria both of which affect gastric dietary protein degradation and leading to pernicious anemia (5) . Second, monkey No. 7, despite a near total loss of oxyntic cells was able to stabilize its body weight suggesting that cynomolgus monkeys may be capable of compensating for the presumed PCB-induced pepsin decrease through alternate processes of protein degradation.
The incidence of tarsal gland dilatation was similar in the two groups, 83% and 80% for the 5 mg Aroclor 1254/kg and the 2 mg Aroclor 1248/kg, respectively. These findings suggeted that either Aroclor 1248 was more toxic in this respect, or that the threshold level at which tarsal gland dilatation occurred was exceeded in both groups.
Despite the differences in dose-levels, duration of treatment and considerable variation in the response of the individual monkeys, it appears that the pattern of response of the hemopoietic system in the treated groups, was Aroclor specific. Thus, monkeys treated with Aroclor 1254 mainifested a fairly uniform picture of reduced erythropoiesis expressed clinically as a mild normocytic nonregenerative anemia, while those treatpd with Aroclor 1248 showed a vigorous bGt ineffective erythropoietic activity with other severe hematologic disturbances.
The three monkeys previously treated with Aroclor 1254 should be considered separately since each monkey manifested a different degree and type of hematologic involvement as shown in Table VI . To what extent observed differences were influenced by previous treatments, the length of the subse-quent treatment or individual response to treatment of the hematopoietic system remains unanswered.
Cytoplasmic and nuclear vacuoles observed in the early erythroid precursors of treated monkeys were of the type seen in chloramphenicol toxicity, reported to be i y reversible in man (14) . Interestingly, similar vacuoles have not been observed in healthy cynomolgus monkeys (8) . A comparison of hematologic observations in this experiment was made with those reported in human PCB poisoning cases, although findings in man are fragmentary and have been described in general, loose terms. Similarities included lower red cell values (3, 12) and slight plasmacytosis observed in the Aroclor 1254 with pretreatment and the Aroclor 1248 groups, and higher reticulocyte and leukocyte values (6, 12) seen in the Aroclor 1248 group; a dissimilarity was the absence of monocytosis as reported in man (6) .
Lymphoreticular lesions seen in these monkeys are perhaps the most important tissue alterations caused by PCB, and interference with immune competence can have deletereous effects on the host. It is suspected that the sudden death of the 2 monkeys in the Aroclor 1248 group was due to failure of the immune system to protect against bacteremia. The observed reduction in size and absence of germinal centers in a number of PCB-treated monkeys are indicative of an interference with the thymus-independent zones of lymphoid follicles. It is clear that monitors of immunologic function are likely to provide the most sensitive measures of toxicity in future research.
PCB-induced gastric mucosal lesions in the cynomolgus, although more severe in the monkeys in the Aroclor 1254 group, can at best be characterized as moderate. Only one monkey treated with Aroclor 1254 (5 mg/day for 135 days and preceded by 0.1 mg/day for 238 days), developed diffuse mucinous hy.perplastic gastropathy with cystic dilatation of gastric glands, early invasion of the submucosa, and near complete loss of oxyntic cells. The remaining stomach showed some form of mucinous hypertrophic and hyperplastic gastropathy with only a small portion developing cystic dilatation of. the gastric glands. A logical explanation for this apparently erratic response of the cynomolgus gastric mucosa cannot be provided at this time since, because of the observed variability in PCB TOXICITY IN CYNOMOLGUS TOXICOLOGIC PATHOLOGY the length of survival of treated monkeys, the role of total dose administered could not be adequately evaluated. When compared with the rat, an interesting but not easily explainable aberration of the cynomolgus response to PCB treatment was the absence of intestinal metaplasia (intestinalization) of the gastric mucosa. Hepatic lesions, namely cellular enlargement, ground glass appearance of the cytoplasm and necrosis of single or clusters of hepatocytes, are compatible with chlorinated hydrocarbon toxicity. Although these lesions seem to belong to the class of reversible or repairable hepatic lesions, they were severe enough to cause in both groups a progressive elevation of serum enzymes. The significance of biliary duct epithelial hyperplasia cannot be determined with certainty at this time. Biliary excretion function tests are required to assess the patency level of the intrahepatic biliary tree. It is suggested, however, that, given the absence of biliary canalicular distension by retained bile, biliary excretion may have been unaffected.
Thyroid follicular lesions, most severe in monkeys in the Aroclor 1254 group, resembled those previously decribed in rats including expanded cytoplasmic area, altered nuclear cytoplasmic ratio, accumulation of lysosomal bodies and hyperplasia of follicular cells (lo). Although such PCB-induced lesions in the rat are related to significant reduction in blood serum thyroxin levels [lo), their presence in PCB-treated monkeys would suggest a similar effect. However, a definitive explanation of the significance of these lesions must await the results of studies now in progress in which thyroid function tests and morphologic evaluations are combined.
The results of this pilot study, using high doses of Aroclor 1254 and 1248 in cynomolgus monkeys, demonstrated that although this species does develop some of the clinical signs and lesions of PCB toxicity ob2trved in man and in rhesus monkeys, the 'aqset of such signs was not as rapid and uniform as reported in other studies. These results cast some doubt upon the suitability of the cynomolgus monkey as an animal model for the study of PCB toxicity. Further research is needed to quantitate and define differences between rhesus and cynomolgus monkeys using Aroclor 1254, the PCB that most closely resembles that present in fish (28) . 
